SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-080784
Filing Date
2024-03-28
Accepted
2024-03-28 16:46:03
Documents
14
Period of Report
2024-03-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d788562d8k.htm   iXBRL 8-K 27061
2 EX-99.1 d788562dex991.htm EX-99.1 7322
  Complete submission text file 0001193125-24-080784.txt   164950

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA thrd-20240327.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE thrd-20240327_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thrd-20240327_pre.xml EX-101.PRE 11718
17 EXTRACTED XBRL INSTANCE DOCUMENT d788562d8k_htm.xml XML 3778
Mailing Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111
Business Address 1700 MONTGOMERY STREET SUITE 210 SAN FRANCISCO CA 94111 2097272457
Third Harmonic Bio, Inc. (Filer) CIK: 0001923840 (see all company filings)

IRS No.: 834553503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41498 | Film No.: 24799895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)